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Abstract
Sporadic ovarian cancer is a particularly aggressive tumor characterized by highly abnormal karyotypes exhibiting
many features of genomic instability. More complex genomic changes in tumors arise as a consequence of chro-
mosomal instability (CIN), which can generate both numerical [(N)-CIN] and structural chromosomal instability [(S)-
CIN]. In this study, molecular cytogenetic analysis was used to evaluate the relative levels of both (N)-CIN and
(S)-CIN. Six tumors had a near-diploid chromosome number, two were near-tetraploid, and two were near-triploid.
(N)-CIN levels increased as a function of overall tumor genomic content, with near-diploid tumors exhibiting nu-
merical instability indices ranging from 7.0 to 21.0 and near-tetraploid and triploid tumors exhibiting instability in-
dices ranging from 24.9 to 54.9. In contrast, the extent of (S)-CIN was generally more evident in the diploid tumors
compared with the near-tetraploid tumors. To determine whether the associated chromosomal constitution and/or
ploidy changes were influenced by mitotic segregation errors, centrosome analyses were performed on all 10 tu-
mors. The near-diploid tumors, with the lowest numerical change, were observed to possess fewer cells with
centrosome abnormalities (5.5% to 14.0%), whereas the near-tetraploid tumors possessed much higher levels
of (N)-CIN and were characterized by a trend of elevating percentages of cells with abnormal centrosomes
(16.0% to 20.5%). These observations suggest that two distinct processes governing genome stability may be
disrupted in ovarian cancer: those that impact on numerical segregation and ploidy of chromosomes and those
that affect the fidelity of DNA repair and lead to structural aberrations.
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Introduction
Ovarian cancer is the leading cause of death from a gynecological
malignancy and the fourth leading cause of cancer death among
North American women. The karyotypes of these tumors are char-
acterized as aneuploid with complex chromosomal aberrations [1–5].
The features of many epithelial tumors, including ovarian cancer, are
the presence of structural changes and aneuploidy, arising as a con-
sequence of chromosomal instability (CIN) [6,7]. CIN has been clas-
sically defined as the rate of whole chromosomal gains and losses
[8,9] and has been a useful means for assessing genomic heterogeneity.
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CIN has also been less frequently used to describe the presence of
structural aberrations [7,10]. More complex genomic changes in tu-
mors arise as a consequence of CIN, which can generate both numer-
ical [(N)-CIN] and structural chromosomal instability [(S)-CIN].
The observed high levels of aneuploidy and structural complexity
in these tumors suggest errors in DNA repair, mitotic segregation
errors, and dysregulation of cell cycle checkpoints [11,12] may gen-
erate (N)-CIN. However, the mechanisms that influence structural
changes and gross aneuploidy are distinct. Structural rearrangements
appear to be influenced by abnormal DNA repair pathways that re-
sult in errors in both homologous and nonhomologous end-joining
of double-stranded DNA and may contribute to (S)-CIN [13] (re-
viewed in Bayani et al. [14]). The formation of structural rearrange-
ments may also come about through telomere-mediated events,
where critically short telomeres are recognized as DNA breaks capa-
ble of recombining either homologously or nonhomologously when
DNA-repair pathways are compromised and telomerase is activated
[15]. In contrast to structural changes, aneuploidy arises through var-
ious mechanisms predominantly influenced by the dysregulation of
cell cycle checkpoints and mitotic segregation errors [11,16].
Tetraploidy is a common feature of many carcinomas and sarco-
mas and is believed to be an initial stage in the development of
aneuploidy, arising either through disruption of chromosome segre-
gation during mitosis [17] or through failure of cytokinesis [18]. The
tetraploidization event not only results in the doubling of genomic
content, but also in the doubling of centrosomes [18,19]. Aneu-
ploidy can also arise from mechanisms independent of a tetraploid
intermediate, suggesting that the components of the mitotic machin-
ery possess aberrant function, such as the loss of centrosome dupli-
cation control, leading to abnormal centrosome amplification and
creating multipolar spindles and unequal genomic segregation [20].
Cytogenetic analyses of primary ovarian carcinomas have identi-
fied tumors with a range of numerical change, from near-diploid
to highly aneuploid abnormal karyotypes. Moreover, within most re-
ported studies, some tumors also have many chromosomes with a
high degree of structural aberration, whereas others exhibited rela-
tively few, simple rearrangements [1–4]. Defining these varying char-
acteristics in greater detail using primary ovarian cancer samples will
provide insights concerning the mechanisms responsible for genomic
diversity in these tumors. Recognition of such mechanisms associated
with each class of chromosomal aberration will be beneficial in un-
derstanding the nature of karyotypic progression as well as opens ave-
nues for future therapeutic strategies in ovarian carcinoma. Using
integrative molecular cytogenetic analyses including spectral karyo-
typing (SKY), comparative genomic hybridization, and interphase
fluorescence in situ hybridization (FISH), 10 sporadic primary ovar-
ian cancer specimens derived from seven patients, previously de-
scribed by our group [4], were assessed for features of (N)-CIN
and (S)-CIN in addition to centrosome amplification.
Materials and Methods
Patient Specimens and Cell Lines
Ten tumors from seven patients with sporadic ovarian cancer, and
who gave informed consent, were obtained from The University
Health Network, Toronto, during the years 2000-2001. All tumors,
except for OCA27A/B and OCA714, were previously described by
Bayani et al. [4]. These patients had no previous family history for
ovarian or breast cancer, and all specimens were obtained at the first
surgery before treatment. For three patients, two distinct tumor sam-
ples were obtained. OCA21A/OCA21B and OCA27A/OCA27B are
paired primary/metastasis samples. For OCA15A/B, tumors were ob-
tained from the right and left ovaries, respectively. A normal female
control fibroblast (passage 9) was also maintained in culture and used
as a technical control.
Peptide Nucleic Acid Fluorescence In Situ Hybridization and
Spectral Karyotyping Analysis
Cell culture and chromosome preparation. Primary tissues were
obtained at the time of surgery and promptly minced and treated
with collagenase (Invitrogen, Burlington, Canada) for 24 hours at
37°C in a CO2 incubator. The following day, the disaggregated tissue
was processed for short-term culture and then prepared for cytoge-
netic harvest as previously described [4]. A normal control fibroblast
culture was maintained and processed similarly.
Peptide Nucleic Acid Fluorescence In Situ Hybridization. For
CIN studies, interphase FISH was performed using peptide nucleic
acid (PNA) probes directly labeled with either fluorescein isothio-
cyanate or Rhodamine for centromeres 2, 4, 7, and 8 (Applied Bio-
systems, Foster City, CA). Pan-centromeric PNA probes (Applied
Biosystems) were also used to identify the presence of multicentro-
meric chromosomes. The standard technique for PNA FISH was car-
ried out as previously published by Wan et al. [21]. Two hundred
nuclei were assessed in a coded fashion by two independent observers.
Generation of instability index. Each tumor specimen was as-
sessed using all four PNA centromere probes. An instability index
was generated based on published criteria by Lengauer et al. [8].
For each specimen, including a normal fibroblast, 200 nuclei were
counted. The normal fibroblast sample served as a technical control
for the overall hybridization efficiency for each centromere probe
used and was found to be greater than 96% (Table W1), with the
average background noise across all centromere probes tested to be
3.6% [(2 + 3.5 + 4 + 4)/4)]. For the tumor specimens, the prevalent
clones for each centromere probe tested were initially established by
karyotypic (SKY) analysis, and the percentage of cells containing
greater or less than that clonal population were enumerated. In keep-
ing with guidelines of clonality [22], if it was determined that the
prevalent signal count for that centromere was not consistent with
the karytoype analysis, the interphase FISH results were used in
our analysis. Populations greater than 30% were identified and were
considered as an additional clone and excluded from the enumera-
tion. For example, in OCA3, the total percentage of cells possessing
greater or less than four signals for centromere 2 was 52%; for cen-
tromere 4, the total percentage of cells possessing greater or less than
two signals per cell was 24.5%; for centromere 7, the total percentage
of cells possessing greater or less than four signals per cell was 37%;
and for centromere 8, the total percentage of cells possessing greater
or less than three signals per cell was 22%. Thus, the average CIN
index is 33.9 [(52 + 24.5 + 37 + 22)/4].
Spectral karyotyping. SKY analysis was performed on metaphase
preparations using the SKY Paints according to the manufacturer’s in-
structions (Applied Spectral Imaging, Carlsbad, CA) and as described
previously by Bayani et al. [4]. Karyotypes derived by SKY analysis
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reflect the clonal changes determined from at least 10 metaphase
spreads where possible. A gain of a chromosome was described when
identified in at least two metaphase spreads, a loss when identified in
three or more cells, and a chromosomal rearrangement when identified
in two or more cells. The karyotype descriptions were assigned accord-
ing to the guidelines set forth by the International System for Cytogenetic
Nomenclature (2005) [22]. Breakpoint enumeration was performed on
intact metaphase spreads that were analyzable. Moreover, only clonal
rearrangements were counted because the number of intact and ana-
lyzable spreads varied from sample to sample. In addition, duplicate
rearrangements were only enumerated once.
Centrosome Immunostaining
For all cases, cells were grown on chambered glass slides and cul-
tured to approximately 70% confluency. The cells were fixed with a
4% paraformaldehyde solution and processed for fluorescence immu-
nohistochemistry with mouse monoclonal anti–γ-tubulin antibodies
(Sigma-Aldrich, Oakville, Canada) as previously described [23]. Cen-
trosome signals were evaluated in 200 nonoverlapping cells. For each
specimen, the percentage of cells possessing greater than two centro-
somes per cell were considered abnormal or if the signal size and
shape were different from the size and shape in control cells [23,24].
The slides were viewed and imaged using a Nikon Labophot-2 fluores-
cent microscope and analyzed using the Vysis Quips SmartCapture
imaging system (Vysis, Downers Grove, Il).
Results
Numerical Chromosomal Instability
To determine (N)-CIN levels within the study group, interphase
FISH was performed using centromere-specific probes from four
representative chromosomes. Centromere probes for chromosomes
2, 4, 7, and 8 were chosen for this study based on their propensity
for net gain (chromosomes 7 and 8), loss (chromosome 4), or ten-
dency for little change (chromosome 2) as determined by previous
cytogenetic and comparative genomic hybridization studies con-
ducted by this group and others [1–5]. The raw scoring data are
detailed in Table W1. Table 1 summarizes the results of interphase
CIN findings using the PNA probes, with representative images from
OCA5, OCA 27B, and OCA714 in Figure 1. An (N)-CIN index was
generated for each tumor as described inMaterials andMethods. Anal-
ysis based on the (N)-CIN indices revealed two distinct ranges of in-
stability: those with a low (N)-CIN index ranging from 7.0 to 21.0,
and another group of tumors with a higher (N)-CIN index ranging
from 24.9 to 54.9. The copy number status of these tumors, as deter-
mined by previous SKY analysis [4], revealed those cases with lower
instability indices possessed karyotypes in the diploid or near-diploid
range. This was in contrast to the second group where the instability
indices were associated with triploid and tetraploid karyotypes. The
tumor that showed the greatest instability was OCA5 (Figure 1A), a
near-triploid tumor with an instability index of 54.9. The results of
the individual chromosomes revealed a range of centromere signals
from one to as many as nine signals per cell for the four chromosomes
tested. OCA3 displayed the next greatest instability index of 33.9. Like
OCA5, OCA3 was characterized as near-triploid; however, the range
of instability was not as extensive as that of OCA5. Among the near-
tetraploid tumors, OCA27A/B, paired primary andmetastatic tumors,
possessed instability indices of 24.9 and 32.7, respectively, for which
the FISH and SKY findings for OCA27B are illustrated in Figure 1B.
OCA15A/B are pair samples showing similar instability indices of
10.7 and 12.7, respectively. Karyotype analysis revealed a hypodiploid
karyotype with numerous structural aberrations similar to both speci-
mens. OCA714 possessed an instability index of 7.0, showing a dip-
loid karyotype as confirmed by SKY analysis (Figure 1C ). When the
(N)-CIN indices were plotted in ascending order (Figure 2), the result-
ing trend revealed that numerical instability increased in association
with transitions in ploidy; specifically, there was very little instability
among the more diploid tumors, whereas near-tetraploid tumors
showed a moderate to high level of instability and near-triploid tumors
showed the greatest level of instability.
Structural Chromosomal Instability
To determine (S)-CIN levels, the number of clonal breakpoints
were enumerated for each case (Table 1) based on previously pub-
lished SKY analysis (Bayani et al., Table W1 [4]), as well as the in-
clusion of three new specimens from two patients. SKY analysis of
OCA27A/B revealed similar tetraploid karyotypes between the pri-
mary and metastatic tumors with complex aberrations. The compos-
ite karyotype for both OCA27A/B is summarized in Table W2. In
the case of OCA714, SKY revealed a highly rearranged karyotype,
where almost every chromosome was involved in a complex aberra-
tion (Table W2 and Figure 1C ). Numerous complex translocations
involved more than three different chromosomes and showed an ex-
tremely high number of breakpoints (n = 83) (Table 1, Figure 1C )
against a diploid background.
The enumeration of the number of clonal aberrations and break-
points showed that diploid and near-diploid tumors possessed ele-
vated DNA breakage events resulting in complex translocations,
inversions, and deletions than whole chromosomal gains and losses
(Table 1, Figure 3, and see Bayani et al., Table W1 [4]). Nondiploid
tumors, however, showed fewer incidences of clonal DNA breakage
Table 1. Summary of (N)-CIN Indices, (S)-CIN Events, and Centrosomal Aberrations in Primary Ovarian Carcinomas.
Case Subtype Ploidy (N)-CIN Index Percentage of Cells with Abnormal Centrosomes (S)-CIN Index
OCA714 Serous 2n− 7.0 20.0 83
OCA15A Endometrioid 2n− 10.7 5.5 58
OCA15B Endometrioid 2n− 12.7 14.0 53
OCA8 Papillary serous 2n+ 21.0 20.0 21
OCA21A Serous 4n/2n 7.6 15.0 26
OCA21B Serous 2n 7.4 11.5 26
OCA27A Serous 4n− 24.9 16.5 29
OCA27B Serous 4n− 32.7 19.0 29
OCA3 Papillary serous 3n 33.9 20.5 43
OCA5 Clear cell 3n+ 54.9 24.0 15
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events, but were associated with copy number changes that were
reflected by the wider range of chromosomes identified per cell.
Moreover, the findings of several duplicate structural changes in
only the tetraploid and triploid cases (Table 1 and see Bayani et al.,
Table W2 [4]) and illustrated by the karyotypic changes in OCA27A/
B, including i(8)(q10)X2, i(14)(q10)X2, der(19)t(19;20)(p11;p11)X2,
der(22)t(11;22)(q14;p11)X2, suggest these rearrangements occurred as
an early event during the diploid stage.
Nonclonal rearrangements were a consistent feature for all the tu-
mors, with diploid and triploid tumors showing a slightly greater fre-
quency of nonclonal aberrations over tetraploid tumors (data not
shown). However, due to the differences in mitotic indices of each
Figure 1. Genomic instability findings in primary ovarian cancers by interphase FISH, SKY, and centrosomal analysis. (A) Genomic in-
stability findings for OCA5. Shown is the histogram generated by interphase FISH analysis using centromere probes 2, 4, 7, and 8. The
x axis represents the number of signals per cell and the y axis shows the percentage of cells. Interphase analysis identified a large
distribution of signals per cell outside the established near-triploid genome. An example of the interphase FISH is shown using centro-
meres 7 (red) and 8 (green) illustrating the variability of centromere signals per cell. Centrosome staining using γ-tubulin (red) illustrates
the presence of supernumerary centrosomes present during cell division and interphase. A representative SKY karyotype is also illus-
trated showing the presence of duplicate rearrangements as well as unique rearrangements. (B) Genomic instability findings for
OCA27B. Shown is the histogram OCA27B. A representative interphase FISH image for centromeres 7 and 8 is also shown as well
as centrosome staining showing a tripolar metaphase and supernumerary centrosomes. A representative SKY karytoype below illus-
trates the near tetraploid karyotype and duplicate markers. (C) Genomic instability findings for OCA714. The histogram for the diploid
tumor OCA714 shows over 95% of cells with two signals for each centromere tested, with a representative interphase FISH image for
centromeres 7 and 8 shown. Supernumerary centrosomes were also detected in a proportion of cells. The SKY karyotype below reveals
the structural complexity of the genome, despite its relatively non-aneuploid status. (D) Examples of multicentric chromosomes using
pan-centromeric FISH probes. Shown are examples from OCA5, OCA714, OCA21B, and OCA27B found to contain multicentric chromo-
somes, including the presence of a ring chromosome in OCA5 (inset) and telomere fusions in OCA714 (inset) as well as typical dicentric
chromosomes in OCA21B and OCA27B (inset).
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specimen and the number of analyzable metaphases, a precise enu-
meration of the total number of nonclonal rearrangements could not
be accurately assessed.
Multicentric Chromosomes
The presence of chromosomal aberrations such as multicentric
chromosomes, are additional hallmarks for genomic instability medi-
ated by bridge-fusion-breakage events or critical telomere shortening
[25,26]. Thus, to determine whether these structures were present in
these tumors, FISH using pan-centromeric PNA probes was per-
formed and revealed the presence of dicentric chromosomes or ring
chromosomes containing multiple pan-centromeric sequences as both
clonal and nonclonal changes. Of the tumors analyzed, OCA8 was the
only tumor that did not show evidence of multicentric chromosomes.
The configurations of multicentromeric chromosomes varied and
were identified as ring chromosomes as in the case of OCA5, telomeric
fusions as detected in OCA714 as well as more typical dicentric con-
figurations as in OCA21B and OCA27B (Figure 1D).
Centrosome Aberrations and Association with
Increasing (N)-CIN
The percentage of cells with an aberrant centrosome was evalu-
ated in all the specimens by fluorescent immunohistochemistry using
anti–γ-tubulin (Table 1). The most abnormal specimen was OCA5
with 24% of cells showing abnormal centrosome configuration or
number (Figure 1A). The corresponding instability for this case, as
previously discussed, was also the highest. Although mitotic figures
were not frequent, abnormal mitoses were detected and shown in
Figure 1B for OCA 27B. OCA3 and OCA27A/B also exhibited fre-
quent centrosome aberrations (Table 1) with percentages of 20.5,
16.5, and 19.0, respectively.
Whereas the observed range of cells containing centrosomal aber-
rations was between 5.5% to 24.0% across all cases, increasing (N)-
CIN indices were generally associated with the increasing frequency
of cells with aberrant centrosomes as summarized in Figure 3. One
case, which failed to follow the general trend, was OCA714, where
the relative (N)-CIN was low (7.0), although the incidence of cen-
trosome abnormalities (20%) was high.
Discussion
The karyotypes of ovarian carcinomas are characterized by aneu-
ploidy and structurally complex chromosomal rearrangements [1–4].
Chromosomal instability (CIN) has traditionally been assessed by the
rate of whole chromosomal copy number changes [9], typically by
interphase FISH analysis using centromere-specific probes. With
the exception of a few recent studies [7,10,27], the potential signifi-
cance and extent of structural changes have been cursory. In this
study, we investigated the relationship between the observed karyo-
typic complexity and ploidy changes observed by structural instabil-
ity [(S)-CIN] and copy number–driven chromosomal instability
[(N)-CIN], respectively, with features associated with aberrant mi-
totic progression in untreated sporadic ovarian carcinomas.
The interphase FISH study and the establishment of (N)-CIN
indices revealed two distinct groups: Group 1 possessed a low range
of (N)-CIN scores (7.0 to 21.0) characterized as near-diploid, and
group 2 possessed a higher range of (N)-CIN scores (24.0 to 54.9),
which were characterized by near-triploid and near-tetraploid kar-
yotypes. The trend observed by the (N)-CIN indices was also seen,
although more subtly, when the enumeration of abnormal centro-
somes was assigned to each case. The increasing frequencies of cells
with abnormal centrosomes were observed to be associated with the
progression from a 2n cell complement to 2n±, then to 4n and 4n±,
through to 3n± (Figure 3). The apparent transition to the tetraploidi-
zation event and subsequent reduction to pseudo-tetraploidy and
(near) triploidy implicates errors in chromosomal segregation and
cytokinesis. This is in keeping with centrosome studies showing the
increased occurrence of mitotic segregation anomalies associated with
centrosome amplification [28,29]. However, the presence of centro-
some amplification does not always commit cells to multipolarity
[30], because centrosome coalescent functions may still remain intact
resulting in normal bipolar division [20,31]. This may explain the
findings of increased centrosome number in some diploid tumors,
but showing relatively low-level (N)-CIN. In this situation, the pres-
ence of aberrant centrosome number or shape/configuration may sim-
ply be an early indicator of a general dysregulation ofmitotic pathways.
Unlike aneuploid genomes (i.e., 3n±, 4n±), which possess sufficient
genomic material to survive the losses of several whole chromosomes
through missegregation and multipolarity; gross missegregation of a
Figure 2. Increasing copy-number instability is associated with transitions in ploidy. Based on the generated CIN indices, increasing CIN
was associated with changes in ploidy. The x axis represents the cases sorted in ascending order based on (N)-CIN indices and the y axis
represents the (N)-CIN indices. *OCA21Awas found to possess a tetraploid karyotype, but containedmany normal contaminating cells by
karyotype analysis. OCA21B possessed a diploid karyotype, but also contained many normal contaminating cells by karyoypte analysis.
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diploid cell may yield daughter cells lacking the genomic material nec-
essary for adequate survival into the next cell cycle. Interestingly,
Rebacz et al. [32] recently identified griseofulvin as an inhibitor of
centrosomal clustering and demonstrated that induction in tumor cell
lines containing extra centrosomes, but maintaining bipolar division,
resulted in loss of centrosomal clustering and multipolar metaphases
leading to cell death. Treatment of normal cells with only two centro-
somes showed no effect on cell viability and centrosomal functioning.
Figure 3. Interplay between (N)-CIN, (S)-CIN, centrosomal aberrations, and ploidy. Illustrated are the (N)-CIN, (S)-CIN, and centrosomal
aberration histograms showing the relationship with CIN indices and ploidy. In this figure, (S)-CIN and centrosome aberrations were
plotted relative to increasing (N)-CIN indices, which were previously shown in Figure 2. As shown here and in Figure 2, during the pro-
gression from 2n± to 4n± to 3n±, the (N)-CIN indices of the tumors tested increased (blue). When the (S)-CIN events were plotted,
we observed more predominant (S)-CIN events in the diploid tumors (green) with lower (N)-CIN indices. Fewer structural events appear
to occur in tetraploid and triploid cancers, whereas their (N)-CIN indices increase. A less prominent trend is seen for the frequency
of supernumerary and abnormal centrosomes (red); however, the cells with more centrosomal alterations were those that were
near-tetraploid and near-triploid. The bottom figure illustrates the interplay between numerical and structural changes as it relates to
changes in ploidy. At initiation, the diploid genome undergoes DNA-damaging events resulting in the accumulation of structural re-
arrangements. Such rearrangements result in accompanying changes in gene expression, affecting all pathways including the cell cycle
and mitosis. Early indicators of cell cycle and mitotic dysregulation can include centrosomal amplification and low-level chromosomal
polysomy while maintaining overall diploidy (bipolar division) during tumor expansion. At some critical point during tumor progression,
the failure of cytokinesis occurs, resulting in the doubling of the genome as well as centrosomes. This event provides the genomic
content and mitotic machinery to undergo gross numerical changes yielding tumor genomes that can assume near-tetraploid or
near-triploid content. Although gross numerical changes are occurring, structural events are ongoing and may again become the pre-
dominant genomic event once a stable ploidy level has been obtained. It can be predicted that another failed cytokinetic event can occur
and the cycle repeated, because 6n± and 5n± tumors have been observed in many cancers.
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This suggests that tumor cells exhibiting centrosomal amplification
andmaintaining centrosomal clustering functions, observed by bipolar
division [or relatively low (N)-CIN], can be selectively targeted.
When the extent of (S)-CIN was investigated through the enu-
meration of clonal breakpoints (resulting from translocations, inver-
sions, deletions), we found diploid and near-diploid tumors (OCA 8,
OCA 15A/B, OCA718) possessed more occurrences of chromosomal
breakage (Table 1). In particular, OCA714 displayed the greatest
number of chromosomal breakages (n = 83), amidst a diploid back-
ground (Table 1). These results suggested significant errors in DNA
repair occurred before gross changes in copy number. Although chro-
mosome breakage events (clonal and nonclonal aberrations) were ob-
served as an ongoing event in the nondiploid cases, we found many
complex rearrangements occurring as duplicates in near-tetraploid or
near-triploid cases, indicating these rearrangements occurred before
the tetraploidization of the genome. The presence of nonclonal chro-
mosomal rearrangements across all tumor specimens indicated that
errors in DNA repair were an ongoing event in the evolution of the
tumor genome; however, it was noted that the diploid and triploid
tumors showed slightly more nonclonal changes that were generally
more structurally complex. The presence of multicentric chromo-
somes in all cases except for OCA8 further supports the notion that
impaired DNA repair is an early event. Studies have shown the pres-
ence of such structures are mediated by the bridge-fusion-breakage
cycle, described as a cycle involving chromatid breaks and fusions trig-
gered by dicentric and ring chromosome rupture during anaphase res-
olution [33]. This self-perpetuating process gives rise to amplifications
(HSRs, ladder amplifications), complex chromosomal rearrange-
ments, inverted repeats, interstitial deletions, and large duplications
[34,35]. The occurrence of telomere fusions in some cases also impli-
cates telomere shortening as a mechanism for generating the observed
genomic instability [36] and has been described by Gisselsson et al.
[26,37]. The most striking result of the (S)-CIN study was the finding
of numerous DNA breakage events that were independent of copy
number changes. The limitation of such analyses, however, is in the
ability of obtaining sufficient metaphases that are analyzable from
short-term primary cultures.
Interestingly, the analysis revealed paired (OCA15A/B) and primary/
metastatic (OCA21A/B and OCA27A/B) specimens showed similar
(N)-CIN and (S)-CIN indices, suggesting the existence of a putative
clonal progenitor. These observations demonstrate that analysis of
recurrent and metastatic samples derived from the same patients can
provide insightful illustrations of the adaptive potential of tumor ge-
nomes during disease progression and in response to treatment.
The molecular cytogenetic analysis of these tumors have revealed
several aspects of (N)-CIN and (S)-CIN, namely, that 1) sporadic
ovarian carcinomas can show a wide range of (N)-CIN; 2) increasing
(N)-CIN and changes in ploidy were associated with the increased
occurrence of centrosome aberrations; and 3) (S)-CIN occurs more
frequently in the diploid stage of karyotypic evolution, implicating a
more prominent role for impaired DNA repair pathways early in
tumor progression. A reevaluation of our previous molecular cytoge-
netic data in primary osteosarcoma and cell lines [23,38–40] has also
shown this interplay between (N)-CIN and (S)-CIN (unpublished
observations) and is recapitulated in current studies (Maire et al., sub-
mitted). Based on these findings, we suggest that both forms of chro-
mosomal aberrations can arise dependently and/or independently of
each other, with one form more prevalent than the other at different
times within the evolution of the tumor genome (Figure 3). Thus, a
delicate balance between (N)-CIN and (S)-CIN processes will influ-
ence the observed levels of structural and numerical change in a tumor.
BRCA1 is strongly associated with ovarian cancer [41] and has been
shown to act as a regulator of DNA damage, repair, and transcription,
and likely has a role in maintaining genomic stability [42]. There is
increasing evidence (reviewed by Deng [42]) suggesting the (S)-CIN
damage response function of BRCA1 can act through RB and p53.
Interestingly, BRCA1 mouse models in breast cancer [43,44] have
demonstrated patterns of aneuploidy and centrosomal amplification
similar to the (N)-CIN findings presented in this study. In keeping
with these observations, Bae et al. [45] demonstrated a role for BRCA1
in regulating the expression of genes implicated in the mitotic spindle
checkpoint, chromosome segregation, centrosome function, cyto-
kinesis, and the progression into and through mitosis resulting in
multinucleated cells and failed cytokinesis.
The concept of tumor ploidy as an indicator of disease aggression
and progression in ovarian cancer has been previously studied pri-
marily by flow or image cytometric analyses [46–48]. The general
consensus of these studies has found that diploid tumors possess a
more favorable response to treatment and survival over those that
are aneuploid. The extensive use of high-throughput microarray anal-
yses has shown the average genomic changes in these tumors include
whole and partial chromosomal gains and losses as well as focal re-
gions of amplification and deletion [5,49,50]. More recently, these
regions of genomic imbalance have been linked to the differential
expression of microRNAs now emerging as important regulators of
protein expression [51–53]. However, although providing detailed
information regarding the net copy-number imbalances, the draw-
back of net/bulk genomic-based analysis is the inference of the tumor
ploidy and rearrangement status in the absence of any parallel inter-
phase or metaphase analyses. This poses a limitation because there is
increasing interest in the karyotypic heterogeneity of tumors as a
measure of genome (in)stability, which is lost when such bulk-based
experiments are performed (reviewed by Bayani et al. [14]). Such
bulk-based studies appear to ignore the potentially significant con-
tributions of polyclonality, which is often considered the source of
“noise” in array analyses and consequently filtered out statistically.
Certainly, as an extreme example, it has been demonstrated that
rare cell populations such as cancer stem cells have a profound and
significant impact on disease recurrence and treatment resistance
[54,55] despite its relatively small population.
In summary, the results of our study have demonstrated both as-
pects of CIN, that is, copy number change and structural change,
should be distinguished. Thus, we propose to differentiate between
these two aspects of CIN: (N)-CIN, characterized by the rate of copy
number changes, and (S)-CIN, characterized by the extent of struc-
tural change and complexity. Indeed we have shown the presence of
(S)-CIN can occur independently of gross copy number or ploidy
changes and that interphase FISH analysis, for copy-number enu-
meration, alone is not sufficient to classify a given specimen as chro-
mosomally unstable. The significance of such a distinction lies in the
mechanisms that mediate the observed changes, providing viable ave-
nues for therapeutic intervention.
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Table W1. Shown Are the Tabulated Data for Each Centromere (Cen) Tested in Control Fibroblasts and Primary Tumors.
Cen 0 1 2 3 4 5 6 7 8 >9 Percentage of Nonclonal Cells CIN Index
Control 2 0 0 98 1 1 0 0 0 0 0 2
4 0 0.5 96.5 2 1 0 0 0 0 0 3.5 3.6
7 0 2.5 96 1 0.5 0 0 0 0 0 4
8 0 2.5 96 1 0.5 0 0 0 0 0 4
OCA3 2 0 0 25.5 24 48 2.5 0 0 0 0 52
4 0 8 74.5 14 2.5 0 0 0 0 0 24.5 33.9
7 0 0.5 16 20 64 0.5 0 0 0 0 37
8 0 1 19 78 1 0.5 0.5 0 0 0 22
OCA5 2 0 1.5 11.5 13 60 6 7 1 0 0 40
4 0 5 22 24 29 14 1 4 0 1 71 54.9
7 0 0.5 20 3 31 31.5 4.5 1 0 4.5 33.5
8 0 0.5 22 15 25 24 7 1 0.5 5 75
OCA8 2 0 0 15.5 80 4.5 0 0 0 0 0 20
4 0 3.5 43.5 34.5 16 1 0.5 0.5 0.5 0 22 21
7 0 2 92 3 3 0 0 0 0 0 8
8 0 0 21 66 9 0.5 3 0.5 0 0 34
OCA15A 2 0 1 92.5 2.5 3 0.5 0.5 0 0 0 7.5
4 0 3 85.5 2.5 9 0 0 0 0 0 14.5 10.7
7 0 0.5 89.5 3 5.5 0.5 1 0 0 0 10.5
8 0 1 89.5 3 6 0 0.5 0 0 0 10.5
OCA15B 2 0 4.5 89 3 3.5 0 0 0 0 0 11
4 0 3.5 83 4 8.5 1 0 0 0 0 17 12.7
7 0 0.5 90 7.5 2 0 0 0 0 0 10
8 0 0.5 87.5 5 7.5 0 0 0 0 0 13
OCA21A 2 0 0 85.5 1 13 0 0.5 0 0 0 1.5
4 0 0 85.5 5.5 6 0.5 1.5 0.5 0 0.5 8.5 7.6
7 0 4.5 88 1.5 5.5 0 0 0.5 0 0 6.5
8 0 8 80 4.5 6 0.5 0 0.5 0.5 0 14
OCA21B 2 0 4 91 3 2 0 0 0 0 0 7
4 0 3.5 81.5 4 9.5 0.5 0 0.5 0.5 0 9 7.4
7 0 4 82.5 4 8 0.5 0 0.5 0.5 0 9.5
8 0 1 89 2.5 7 0 0 0.5 0 0 4
OCA27A 2 0 0 45* 4 9 35 4.5 0 1 1.5 20
4 0 3 36.5* 22.5 32.5 3 0.5 0 1 1 31 24.9
7 0 0 48* 8 41.5 2 0.5 0 0 0 10.5
8 0 1 47* 9 15 12.5 6.5 6.5 1.5 1 38
OCA27B 2 0 1 10* 13.5 60 11.5 1.5 1 1.5 0 30
4 0 1.5 10* 18.5 60 9.5 0.5 0 0 0 30 32.7
7 0 1 14* 20 62 2.5 0.5 0 0 0 24
8 0 0 13* 12 39 20 10 3.5 0.5 1 47
OCA714 2 0 4 90 4.5 1.5 0 0 0 0 0 10
4 0 5 89 3.5 2 0.5 0 0 0 0 11 7
7 0 1 96 1 1 0 1 0 0 0 4
8 0 0 97 0.5 2 0 0 0 0.5 0 3
Two hundred nuclei were enumerated and the values reflect the percentage of cells containing the specified numbers of signals per cell. Bolded values shaded in gray correspond to the number of signals
corresponding to the dominant clone established by karyotype analysis (SKY). In situations where the percentage was equal to or exceeded 30%, this was considered another clonal population. In
addition, cells containing a diploid count corresponding to normal contamination (*) as determined by karyotypic analysis were also excluded. All other cell populations were considered as nonclonal,
which were averaged across all centromere probes used and expressed as the (N)-CIN index.
Table W2. Composite SKY Karyotypes of OCA27A/B and OCA714.
Case SKY Karyotype
OCA27A/B 76-80<4n>,XXXX,der(X)t(X;8)(p22;q22),−1,del(1)(p34),der(2)dup(p11p15),der(2)t(2;17)(p11;11),del(4)(q12),der(5)t(1;5)(p11;q11),−6,i(8)(q10)X2,
der(8)t(2;8)(p11;q11),−9,der(9)t(8;9)(q33;q11),der(12)t(12;22)(p11;q11),−13,−13,der(13)t(X;13)(q11;p11),der(13)t(8;13)(p12;p11),−14,i(14)(q10)X2,
−16,−16,der(5;16)(q22;?),−17,−17,i(17)(q10),der(19)t(19;20)(p11;p11)X2,−20,−20,−22,−22,der(22)t(11;22)(q14;p11)X2{cp5}.
OCA714 41-46,X,−X,der(1)(13qter→13q21∷dup1p21→p22→q11∷5p11→5p14),der(2)t(2;3)(q14;?),der(2)(8qter→q21∷2p16→q23∷20?→20>∷3?→3?),
der(3)(3qter→3q10→3q10∷5?→5?),i13(q10), der(4)(2?→2? ∷4p15→4q24∷2?→2? ∷?→?),−5,der(5)(14qter→14q21∷5p12→15q34∷8?→8?),
der(6)t(6;11)(q10;q13),der(6)(pter→6q10∷22?→22? ∷14q21→14qter),der(7)t(7;19)(q11;q10),der(7)del(p?)del(q?),+der(7)del(p21)del(q31),
der(8)(8pter→8q10∷13q21→13q34∷6?→6?),i(9)(q10),der(9)t(6;9)(?q21:q10),der(10)t(8;10)(?;p14),der(11)(14q?→? ∷11p12→11q10∷2?→2?),
der(12)t(12;21)(q14;?),der(13)(3pter→p11∷13p13→13q32∷15q24→15q26),der(13)t(3;13)(p13;q10),der(14)(14p13→14q24∷9?→? ∷14q24→14qter),
−16,der(16)t(16;20)(q22;q13),−17,−18,der(19)(19pter→19q13.3∷2q22→2q32),−22.
